Molecular remission at T cell level in patients with rheumatoid arthritis
Abstract While numerous disease-modifying anti-rheumatic drugs (DMARDs) have brought about a dramatic paradigm shift in the management of rheumatoid arthritis (RA), unmet needs remain, such as the small proportion of patients who achieve drug-free status. The aim of this study was to explore key mol...
Main Authors: | Jun Inamo, Katsuya Suzuki, Masaru Takeshita, Yasushi Kondo, Yuumi Okuzono, Keiko Koga, Yoshiaki Kassai, Maiko Takiguchi, Rina Kurisu, Akihiko Yoshimura, Tsutomu Takeuchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-96300-z |
Similar Items
-
Identification of novel genes associated with dysregulation of B cells in patients with primary Sjögren’s syndrome
by: Jun Inamo, et al.
Published: (2020-06-01) -
Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission
by: Shinya Tasaki, et al.
Published: (2018-07-01) -
Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
by: Noriko Kimura, et al.
Published: (2019-03-01) -
Significant association between joint ultrasonographic parameters and synovial inflammatory factors in rheumatoid arthritis
by: Yasushi Kondo, et al.
Published: (2019-01-01) -
Notch-mediated conversion of activated T cells into stem cell memory-like T cells for adoptive immunotherapy
by: Taisuke Kondo, et al.
Published: (2017-05-01)